Christine Leowardi1, Marie-Luise Schneider2, Ulf Hinz2, Jonathan M Harnoss2, Ignazio Tarantino2, Felix Lasitschka3, Alexis Ulrich2, Markus W Büchler2, Martina Kadmon2. 1. Department of General, Visceral and Transplantation Surgery,, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany. christine.leowardi@med.uni-heidelberg.de. 2. Department of General, Visceral and Transplantation Surgery,, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany. 3. Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
Abstract
BACKGROUND: Ulcerative colitis (UC) patients have an increased risk of developing colorectal carcinoma (CRC). In contrast to clinical and pathogenetic differences, little is known about how prognosis compares between these patients and those with sporadic CRC. The aim of this study was to compare their characteristics and prognosis and identify independent risk factors for patients with UC-associated CRC. METHODS: A total of 126 patients who underwent surgery in our department (1984-2010) for UC-associated (n = 63) or sporadic (n = 63) CRC were included in this analysis. Patients were matched according to sex, tumor location, and disease stage. Clinical parameters and overall, recurrence-free, and disease-specific survival were compared. In subgroup analyses, clinical parameters of UC patients were correlated with survival. RESULTS: Median follow-up was 129 months in the UC group and 99 months in the sporadic CRC group. UC patients were significantly younger and had more multifocal, high-grade, and mucinous carcinomas. Five-year overall survival rate for UC-associated and sporadic CRC was similar (65.7 vs. 63.2%, p = 0.98). Recurrence-free survival for International Union Against Cancer (UICC) stage II disease was superior in the sporadic CRC group (p = 0.039). In a subgroup analysis of UC patients, a shorter duration of UC (p = 0.045) and male sex (p = 0.005) were associated with a worse prognosis. CONCLUSIONS: Despite multiple clinical and histopathologic differences between UC-associated and sporadic CRC patients, overall survival and disease-specific survival are similar. In a subgroup analysis of UC patients with CRC, female sex was associated with a significantly better prognosis. This finding implies that estrogens may play a protective role in UC-associated CRC carcinogenesis.
BACKGROUND:Ulcerative colitis (UC) patients have an increased risk of developing colorectal carcinoma (CRC). In contrast to clinical and pathogenetic differences, little is known about how prognosis compares between these patients and those with sporadic CRC. The aim of this study was to compare their characteristics and prognosis and identify independent risk factors for patients with UC-associated CRC. METHODS: A total of 126 patients who underwent surgery in our department (1984-2010) for UC-associated (n = 63) or sporadic (n = 63) CRC were included in this analysis. Patients were matched according to sex, tumor location, and disease stage. Clinical parameters and overall, recurrence-free, and disease-specific survival were compared. In subgroup analyses, clinical parameters of UC patients were correlated with survival. RESULTS: Median follow-up was 129 months in the UC group and 99 months in the sporadic CRC group. UC patients were significantly younger and had more multifocal, high-grade, and mucinous carcinomas. Five-year overall survival rate for UC-associated and sporadic CRC was similar (65.7 vs. 63.2%, p = 0.98). Recurrence-free survival for International Union Against Cancer (UICC) stage II disease was superior in the sporadic CRC group (p = 0.039). In a subgroup analysis of UC patients, a shorter duration of UC (p = 0.045) and male sex (p = 0.005) were associated with a worse prognosis. CONCLUSIONS: Despite multiple clinical and histopathologic differences between UC-associated and sporadic CRC patients, overall survival and disease-specific survival are similar. In a subgroup analysis of UC patients with CRC, female sex was associated with a significantly better prognosis. This finding implies that estrogens may play a protective role in UC-associated CRC carcinogenesis.
Authors: Ian S Reynolds; Aobhlinn O'Toole; Joseph Deasy; Deborah A McNamara; John P Burke Journal: Int J Colorectal Dis Date: 2017-01-11 Impact factor: 2.571
Authors: Viviane A Lin; Robin Lohse; Michael T Madsen; Tina Fransgaard; Feza H Remzi; Ismail Gögenur Journal: Ann Surg Oncol Date: 2021-09-05 Impact factor: 5.344
Authors: Rona Yaeger; Manish A Shah; Vincent A Miller; Judith R Kelsen; Kai Wang; Zachary J Heins; Jeffrey S Ross; Yuting He; Eric Sanford; Rhonda K Yantiss; Sohail Balasubramanian; Philip J Stephens; Nikolaus Schultz; Moshe Oren; Laura Tang; David Kelsen Journal: Gastroenterology Date: 2016-04-08 Impact factor: 22.682
Authors: Yoon Dae Han; Mahdi Hussain Al Bandar; Audrius Dulskas; Min Soo Cho; Hyuk Hur; Byung Soh Min; Kang Young Lee; Nam Kyu Kim Journal: BMC Surg Date: 2017-03-21 Impact factor: 2.102
Authors: Leonie E Vetter; Susanne Merkel; Alan Bénard; Christian Krautz; Maximilian Brunner; Anke Mittelstädt; Nicolas Schlegel; Armin Wiegering; Christoph-Thomas Germer; Klaus Weber; Robert Grützmann; Georg F Weber Journal: Int J Colorectal Dis Date: 2020-09-12 Impact factor: 2.571